Copyright Reports & Markets. All rights reserved.

Global Vasopressin Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Vasopressin Product Introduction
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Vasopressin Market Size Growth Rate by Type
      • 1.4.2 Intravenous Injection
      • 1.4.3 Intramuscular Injection
      • 1.4.4 Subcutaneous Injection
    • 1.5 Market by Application
      • 1.5.1 Global Vasopressin Market Size Growth Rate by Application
      • 1.5.2 Anti-Diuretic Hormone Deficiency
      • 1.5.3 Vasodilatory Shock
      • 1.5.4 Gastrointestinal Bleeding
      • 1.5.5 Ventricular Tachycardia & Fibrillation
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Vasopressin Market Size
      • 2.1.1 Global Vasopressin Revenue 2014-2025
      • 2.1.2 Global Vasopressin Sales 2014-2025
    • 2.2 Vasopressin Growth Rate by Regions
      • 2.2.1 Global Vasopressin Sales by Regions
      • 2.2.2 Global Vasopressin Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Vasopressin Sales by Manufacturers
      • 3.1.1 Vasopressin Sales by Manufacturers
      • 3.1.2 Vasopressin Sales Market Share by Manufacturers
    • 3.2 Vasopressin Revenue by Manufacturers
      • 3.2.1 Vasopressin Revenue by Manufacturers (2014-2019)
      • 3.2.2 Vasopressin Revenue Share by Manufacturers (2014-2019)
    • 3.3 Vasopressin Price by Manufacturers
    • 3.4 Vasopressin Manufacturing Base Distribution, Product Types
      • 3.4.1 Vasopressin Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Vasopressin Product Type
      • 3.4.3 Date of International Manufacturers Enter into Vasopressin Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type

    • 4.1 Global Vasopressin Sales by Type
    • 4.2 Global Vasopressin Revenue by Type
    • 4.3 Vasopressin Price by Type

    5 Breakdown Data by Application

    • 5.1 Overview
    • 5.2 Global Vasopressin Breakdown Data by Application

    6 North America

    • 6.1 North America Vasopressin by Country
      • 6.1.1 North America Vasopressin Sales by Country
      • 6.1.2 North America Vasopressin Revenue by Country
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Vasopressin by Type
    • 6.3 North America Vasopressin by Application

    7 Europe

    • 7.1 Europe Vasopressin by Country
      • 7.1.1 Europe Vasopressin Sales by Country
      • 7.1.2 Europe Vasopressin Revenue by Country
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Vasopressin by Type
    • 7.3 Europe Vasopressin by Application

    8 Asia Pacific

    • 8.1 Asia Pacific Vasopressin by Country
      • 8.1.1 Asia Pacific Vasopressin Sales by Country
      • 8.1.2 Asia Pacific Vasopressin Revenue by Country
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Vasopressin by Type
    • 8.3 Asia Pacific Vasopressin by Application

    9 Central & South America

    • 9.1 Central & South America Vasopressin by Country
      • 9.1.1 Central & South America Vasopressin Sales by Country
      • 9.1.2 Central & South America Vasopressin Revenue by Country
      • 9.1.3 Brazil
      • 9.1.4 Argentina
    • 9.2 Central & South America Vasopressin by Type
    • 9.3 Central & South America Vasopressin by Application

    10 Middle East and Africa

    • 10.1 Middle East and Africa Vasopressin by Country
      • 10.1.1 Middle East and Africa Vasopressin Sales by Country
      • 10.1.2 Middle East and Africa Vasopressin Revenue by Country
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Vasopressin by Type
    • 10.3 Middle East and Africa Vasopressin by Application

    11 Company Profiles

    • 11.1 Novartis
      • 11.1.1 Novartis Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Novartis Vasopressin Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Novartis Vasopressin Products Offered
      • 11.1.5 Novartis Recent Development
    • 11.2 Pfizer
      • 11.2.1 Pfizer Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Pfizer Vasopressin Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Pfizer Vasopressin Products Offered
      • 11.2.5 Pfizer Recent Development
    • 11.3 Fresenius Kabi Canada
      • 11.3.1 Fresenius Kabi Canada Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Fresenius Kabi Canada Vasopressin Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Fresenius Kabi Canada Vasopressin Products Offered
      • 11.3.5 Fresenius Kabi Canada Recent Development
    • 11.4 Par Pharmaceutical
      • 11.4.1 Par Pharmaceutical Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Par Pharmaceutical Vasopressin Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Par Pharmaceutical Vasopressin Products Offered
      • 11.4.5 Par Pharmaceutical Recent Development
    • 11.5 Ferring Pharmaceuticals
      • 11.5.1 Ferring Pharmaceuticals Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Ferring Pharmaceuticals Vasopressin Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Ferring Pharmaceuticals Vasopressin Products Offered
      • 11.5.5 Ferring Pharmaceuticals Recent Development
    • 11.6 Astellas Pharma
      • 11.6.1 Astellas Pharma Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Astellas Pharma Vasopressin Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Astellas Pharma Vasopressin Products Offered
      • 11.6.5 Astellas Pharma Recent Development
    • 11.7 Shanghai Soho-Yiming Pharmaceuticals
      • 11.7.1 Shanghai Soho-Yiming Pharmaceuticals Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Shanghai Soho-Yiming Pharmaceuticals Vasopressin Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Shanghai Soho-Yiming Pharmaceuticals Vasopressin Products Offered
      • 11.7.5 Shanghai Soho-Yiming Pharmaceuticals Recent Development

    12 Future Forecast

    • 12.1 Vasopressin Market Forecast by Regions
      • 12.1.1 Global Vasopressin Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Vasopressin Revenue Forecast by Regions 2019-2025
    • 12.2 Vasopressin Market Forecast by Type
      • 12.2.1 Global Vasopressin Sales Forecast by Type 2019-2025
      • 12.2.2 Global Vasopressin Revenue Forecast by Type 2019-2025
    • 12.3 Vasopressin Market Forecast by Application
    • 12.4 North America Vasopressin Forecast
    • 12.5 Europe Vasopressin Forecast
    • 12.6 Asia Pacific Vasopressin Forecast
    • 12.7 Central & South America Vasopressin Forecast
    • 12.8 Middle East and Africa Vasopressin Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Vasopressin Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Vasopressin is a nine amino acid peptide secreted from the posterior pituitary. Antidiuretic hormone binds to receptors in the distal or collecting tubules of the kidney and promotes reabsorbtion of water back into the circulation.
      The global Vasopressin market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Vasopressin market based on company, product type, end user and key regions.

      This report studies the global market size of Vasopressin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Vasopressin in these regions.
      This research report categorizes the global Vasopressin market by top players/brands, region, type and end user. This report also studies the global Vasopressin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Novartis
      Pfizer
      Fresenius Kabi Canada
      Par Pharmaceutical
      Ferring Pharmaceuticals
      Astellas Pharma
      Shanghai Soho-Yiming Pharmaceuticals

      Vasopressin market size by Type
      Intravenous Injection
      Intramuscular Injection
      Subcutaneous Injection
      Vasopressin market size by Applications
      Anti-Diuretic Hormone Deficiency
      Vasodilatory Shock
      Gastrointestinal Bleeding
      Ventricular Tachycardia & Fibrillation

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      Turkey
      GCC Countries
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Vasopressin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Vasopressin market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Vasopressin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Vasopressin submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Vasopressin are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Vasopressin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now